Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

Clinical trial NCT00551070 · COMPLETED

Trial details

NCT number: NCT00551070
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Ovarian Serous Tumor Low Grade Ovarian Serous Adenocarcinoma Micropapillary Serous Carcinoma Primary Peritoneal Carcinoma Primary Peritoneal Low Grade Serous Adenocarcinoma Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor

Start date: 2007-12-17
Primary completion: 2013-07-23
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.